Home > Insider Trading > Filing (0001213900-19-005843)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1506251	Citius Pharmaceuticals Inc.	CTXR	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1199080	Z Myron Holubiak	C/O Citius Pharmaceuticals, Inc. 11 Commerce Drive, 1St Floor Cranford NJ 07016	President And Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-04-03	129,450	$1.55	1,433,646	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2019-04-03	129,450	$0.00	129,450	$1.42

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
129,450		2021-04-05	No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant to Purchase Common Stock	$1.15	2023-08-14	784,314	784,314	Direct
Common Stock	Options to Purchase Common Stock	$8.10	2025-10-01	26,667	26,667	Direct
Common Stock	Options to Purchase Common Stock	$3.45	2027-09-13	40,000	40,000	Direct
Common Stock	Warrant to Purchase Common Stock	$6.21	2019-06-12	19,615	19,615	Direct
Common Stock	Options to Purchase Common Stock	$1.62	2028-09-04	150,000	150,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2023-08-14	784,314	784,314	Direct
2025-10-01	26,667	26,667	Direct
2027-09-13	40,000	40,000	Direct
2019-06-12	19,615	19,615	Direct
2028-09-04	150,000	150,000	Direct

Footnotes

The warrant is fully vested and exercisable immediately.
The purchase price of the warrants was included in the purchase price of the common stock reported in Table I.
The option granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.
One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest.
One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.